Biosensors & bioelectronics

Using modified carbon nanotubes to improve CRISPR/Cas12a detection of hepatitis C virus with a DNA-based signal amplifier

Updated

Abstract

Detection limits of 0.23 fM for fluorescence and 4.1 fM for colorimetric modes were achieved in HCV RNA detection.

  • A dual-modal biosensing platform integrates fluorescence and colorimetric readouts for HCV RNA detection.
  • The presence of HCV RNA triggers a catalytic assembly circuit that generates a Y-shaped DNA structure.
  • This structure activates CRISPR/Cas12a nuclease activity, leading to signal amplification for sensitive detection.
  • Hemin-binding aptamer-functionalized single-walled carbon nanotubes enhance sensitivity by quenching fluorescence and oxidizing a dye.
  • In the presence of target HCV RNA, signal interference occurs, allowing for fluorescence recovery and reduced dye oxidation.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free